Parenting Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
Information on ADHD Medications »
ADHD medications are drugs used to treat some of the characteristic behaviors associated with attention deficit hyperactivity disorder, including inattention, hyperactivity, and poor impulse control.
Drugs used to treat ADHD target chemicals in the brain known as neurotransmitters. One type of ADHD medication works by increasing levels of the neurotransmitter dopamine. Another type of ADHD drug increases the level of another neurotransmitter, norepinephrine.
ADHD drug treatment should begin only after a specific diagnosis of ADHD has been made. A clinical diagnosis requires that symptoms have persisted for at least six months. There is no blood test or radiological scan that can diagnose ADHD.
Most children with ADHD are diagnosed in preschool or early in elementary school. It's estimated that up to 7%-8% of school-age children in the United States have ADHD. In addition, it may be present ...
MEDICATION GUIDE
Daytrana™
(day-TRON-ah)
(methylphenidate transdermal system)
Important: Only Use on Skin
Read the Medication Guide that comes with Daytrana™ (methylphenidate transdermal) before you or your child starts using it and each time you get a refill. There may be new information. This Medication Guide does not take the place of talking to your doctor about your or your child's treatment with Daytrana™ (methylphenidate transdermal) .
What is the most important information I should know about Daytrana™ (methylphenidate transdermal) ?
Daytrana™ (methylphenidate transdermal) is a stimulant medicine. The following have been reported with use of Daytrana™ (methylphenidate transdermal system) or other stimulant medicines:
1. Heart-related problems:
Tell your doctor if you or your child has any heart problems, heart defects, high blood pressure, or a family history of these problems.
Your doctor should check you or your child carefully for heart problems before starting Daytrana™ (methylphenidate transdermal) .
Your doctor should check your or your child's blood pressure and heart rate regularly during treatment with Daytrana™ (methylphenidate transdermal) .
Remove patch immediately and call your doctor right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting while using Daytrana™ (methylphenidate transdermal) .
2. Mental (Psychiatric) problems:
All Patients
Children and Teenagers
Tell your doctor about any mental problems you or your child has, or about a family history of suicide, bipolar illness, or depression.
Call your doctor right away if you or your child has any new or worsening mental symptoms or problems while using Daytrana™ (methylphenidate transdermal) , especially seeing or hearing things that are not real, believing things that are not real, or are suspicious.
What Is Daytrana™ (methylphenidate transdermal) ?
Daytrana™ (methylphenidate transdermal) is a central nervous system (CNS) stimulant prescription medicine. Daytrana™ (methylphenidate transdermal) is a skin patch that releases the medication contained in the adhesive (glue) through clean and intact skin areas into the bloodstream when applied to the skin on the hips. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). Daytrana™ (methylphenidate transdermal) may help increase attention and decrease impulsiveness and hyperactivity in patients with ADHD.
Daytrana™ (methylphenidate transdermal) should be used as a part of a total treatment program for ADHD that may include counseling or other therapies.
The Daytrana™ (methylphenidate transdermal) patch has 3 layers. The 3 layers are displayed and described in the figures below. The figures below display both sides of a patch:
![]() |
Protective liner: the layer that is removed prior to applying the patch to the skin.
Adhesive with medicine: After the protective liner is removed, this is the side of the patch that sticks to the skin.
Outside backing: This is what you will see after the patch is put on the skin. The word “Daytrana™ (methylphenidate transdermal) ” is printed on this side.
Daytrana™ (methylphenidate transdermal) is a federally controlled substance (CII) because it can be abused or lead to dependence. Keep Daytrana™ (methylphenidate transdermal) in a safe place to prevent misuse and abuse. Selling or giving away Daytrana™ (methylphenidate transdermal) may harm others, and is against the law.
Tell your doctor if you or your child has (or has a family history of) ever abused or been dependent on alcohol, prescription medicines or street drugs.
Who should not use Daytrana™ (methylphenidate transdermal) ?
Daytrana™ (methylphenidate transdermal) should not be used if you or your child:
Daytrana™ (methylphenidate transdermal) should not be used in children less than 6 years old because it has not been studied in this age group.
Daytrana™ (methylphenidate transdermal) may not be right for you or your child. Before starting Daytrana™ (methylphenidate transdermal) tell your or your child's doctor about all health conditions (or a family history of) including:
Tell your doctor if you or your child is pregnant, planning to become pregnant, or breastfeeding.
Can Daytrana™ (methylphenidate transdermal) be used with other medicines?
Tell your doctor about all of the medicines that you or your child takes including prescription and nonprescription medicines, vitamins, and herbal supplements. Daytrana™ (methylphenidate transdermal) and some medicines may interact with each other and cause serious side effects. Sometimes the doses of other medicines will need to be adjusted while using Daytrana™ (methylphenidate transdermal) .
Your doctor will decide whether Daytrana™ (methylphenidate transdermal) can be used with other medicines.
Especially tell your doctor if you or your child takes:
Know the medicines that you or your child takes. Keep a list of your medicines with you to show your doctor and pharmacist.
Do not start any new medicine while using Daytrana™ (methylphenidate transdermal) without talking to your doctor first.
How should Daytrana™ (methylphenidate transdermal) be used?
Do not use hair dryers, heating pads, electric blankets, heated water beds or other heat sources while wearing a Daytrana™ (methylphenidate transdermal) patch. Too much medicine can pass into your or your child's body and cause serious side effects.
See the complete instructions for applying Daytrana™ (methylphenidate transdermal) at the end of this Medication Guide.
What are possible side effects of Daytrana™ (methylphenidate transdermal) ?
Skin reactions including skin irritation and allergic skin rash can happen with Daytrana™ (methylphenidate transdermal) . Skin redness or itching at the application site is common. You can keep using Daytrana™ (methylphenidate transdermal) if this happens. Stop using Daytrana™ (methylphenidate transdermal) and see your doctor right away if swelling, bumps, or blisters happen at or around the application site. You may have a skin allergy to Daytrana™ (methylphenidate transdermal) . People that have skin allergies with Daytrana™ (methylphenidate transdermal) may develop an allergy to all medicines that contain methylphenidate, even those taken by mouth.
See “What is the most important information I should know about Daytrana™ (methylphenidate transdermal) ” for information on reported heart and mental problems.
Other serious side effects include:
Common side effects include:
|
|
Talk to your doctor if you or your child has side effects that are bothersome or do not go away.
This is not a complete list of possible side effects. Ask your doctor or pharmacist for more information. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088
How should I store Daytrana™ (methylphenidate transdermal) ?
General information about Daytrana™ (methylphenidate transdermal)
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Daytrana™ (methylphenidate transdermal) for a condition for which it was not prescribed. Do not give Daytrana™ (methylphenidate transdermal) to other people, even if they have the same condition. It may harm them and it is against the law.
This Medication Guide summarizes the most important information about Daytrana™ (methylphenidate transdermal) . If you would like more information, talk with your doctor. You can ask your doctor or pharmacist for information about Daytrana™ (methylphenidate transdermal) that was written for healthcare professionals. For more information about Daytrana™ (methylphenidate transdermal) call 1-800-828-2088 or visit www.daytrana (methylphenidate transdermal) .com.
Skin care information about Daytrana™ (methylphenidate transdermal)
Skin redness or itching is common with Daytrana™ (methylphenidate transdermal) , and small bumps on the skin may also occur in some patients. If you have any swelling or blistering, the patch should not be worn and you should consult your doctor. Do not apply any medicine, cream, or lotion on the skin at the Daytrana (methylphenidate transdermal) patch site before applying the patch, since this might affect how the patch sticks to the skin and how the medicine is absorbed from the patch.
INSTRUCTIONS FOR APPLYING DAYTRANA™ (methylphenidate transdermal system)
1. USING THE ADMINISTRATION CHART
Each carton of Daytrana™ (methylphenidate transdermal) contains an administration chart to help parents or caregivers keep track of when the patch is applied each morning, when it is removed and the method of disposal used. Daytrana™ (methylphenidate transdermal) should be worn for about 9 hours.
To use the administration chart, follow these instructions:
Timetable for 9-Hour Daytrana™ (methylphenidate transdermal) Application and Removal
| If you applied the patch at: | Remove the patch at: |
| 5:00 a.m. | 2:00 p.m. |
| 6:00 a.m. | 3:00 p.m. |
| 7:00 a.m. | 4:00 p.m. |
| 8:00 a.m. | 5:00 p.m. |
| 9:00 a.m. | 6:00 p.m. |
| 10:00 a.m. | 7:00 p.m. |
| 11:00 a.m. | 8:00 p.m. |
| 12:00 p.m. | 9:00 p.m. |
2. WHERE TO APPLY DAYTRANA™ (methylphenidate transdermal)
![]() |
3. BEFORE YOU APPLY DAYTRANA™ (methylphenidate transdermal)
The patch should separate easily from the protective liner. Do not use the patch if the protective liner is difficult to remove.
Look at the patch to make sure it is not damaged or defective in any way. After the protective liner is removed, there should not be any adhesive (glue) sticking to the liner.
If the patch is damaged, or you have problems removing it from the liner, discard the patch according to the instructions provided below (see How to Remove and Discard Daytrana™ (methylphenidate transdermal) ), and apply a new one to the child's skin.
Do not use patches that have been stored in the refrigerator or freezer.
Make sure the child's skin is:
4. HOW TO APPLY DAYTRANA™ (methylphenidate transdermal)
![]() |
![]() |
![]() |
![]() |
![]() |
PLEASE NOTE:
5. HOW TO REMOVE AND DISCARD DAYTRANA™ (methylphenidate transdermal)
UNUSED PATCHES
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Last reviewed on RxList: 1/5/2010
This monograph has been modified to include the generic and brand name in many instances.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.